AACC Middle East

A partnership between AACC and Al Borg Medical Laboratories

AACC Middle East is a two-day scientific meeting and clinical laboratory exposition which will bring AACC scientific leadership to a region where there are great interest and enthusiasm for the latest education in laboratory science and diagnostic technology.

Learn about the latest scientific advances in laboratory medicine:

› Laboratory Quality Management and Accreditation
› Clinical Chemistry
› Newborn Screening
› Genetics
› Oncology
› Emerging Topics to the Middle East

AACC Middle East

A partnership between AACC and Al Borg Medical Laboratories

Leaders in laboratory science and management from countries throughout the region including Bahrain, Kuwait, Qatar, Saudi Arabia, United Arab Emirates, Oman, Jordan, Egypt, Turkey, Lebanon, Cyprus, and the entire African continent will be invited to participate. Attendees are comprised of laboratory directors and managers, government officials, and representatives of the diagnostics industry.



Quality and Lab Management
› Jumping the Pediatric Reference Interval Hurdles
› Biological Variation: Improved Interpretation of Lab Results and Reduced False Rejections for QC
› Overdiagnosis and Over monitoring – Can We Do Better?
› Rule-Based Strategies for Improving Laboratory Utilization Management
› Minimum Retesting Intervals (MRI): Importance, Determination, Advantages, Challenges of Enforcement

Autoimmunity and Transplantation Medicine
› Developing Standards in Antinuclear Antibody Indirect Immunofluorescence (ANA IFA) Interpretation and Reporting
› Emerging Trends in Autoimmune and Paraneoplastic Encephalopathy Testing
› The Role of Clinical Laboratory in Transplantation

Clinical Chemistry's Hot Topics
› The Quantified Self and Wellness Monitoring: Actionable Data or Harmful Information?
› Cervical Cancer Screening as an Example of a Global Health Strategy in Resource‐limited Countries
› What Does the Physician Need from the Laboratory?
› A Dirty Assay: Challenges of PTH Estimation and Progress in PTH Harmonization
› Update on Gestational Diabetes Mellitus: Current National and International Diagnostic Criteria

Cardiovascular System
› Real Global News: It’s Time to Embrace High Sensitivity Cardiac Troponin Assays With Cost Benefit Strategies For Early Rule-Out and Rule-In of My
› Clinical Cardiovascular Genomics Bootcamp
› Lipoprotein-related Precision Medicine – Implications in Risk Stratification and Emerging Therapies of Coronary Heart Disease and Aortic Valve D
› Standardization of Traditional and New Cardiovascular Disease Biomarkers – Addressing Cholesterol and Beyond

Molecular Genetics
› Pharmacogenomics in Laboratory Medicine: Moving to an Era of Precision Medicine
› Emerging Clinical Applications of Circulating DNA Analysis
› Quality Control and Quality Assurance in the Era of Next Generation Sequencing
› Noninvasive Prenatal Testing by Cell-Free Fetal DNA: Translating Innovation into Clinical Practice